Basic information
Biomarker: ENLR
Full name: Eosinophil*Neutrophil-to-Lymphocytes ratio
Clinical application: prognosis (unfavorable)
Histology type: endometrial carcinoma
Cohort characteristics
Followed up time : 54.8 (range 24.6-58.4)
Cohort age: 74;89
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 163 | ENLR < 0.5 | 118 | ENLR >=0.5 | 45 |
Sample information
Sample type : serum
Expression pattern : upregulated
Biomarker characteristic: >=0.5
Disease information
Subgroup 1 name: ENLR < 0.5
Subgroup 2 name: ENLR >=0.5
Subgroup 2 number: 45
